Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer.
about
The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancerMiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerPutative biomarkers and targets of estrogen receptor negative human breast cancerIntegrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patientsIntegrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients.Towards understanding the breast cancer epigenome: a comparison of genome-wide DNA methylation and gene expression dataAlu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer.Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary Cancer.DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasiaISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complexIGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.DNA methylation profiles of airway epithelial cells and PBMCs from healthy, atopic and asthmatic childrenTranscription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors.DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survivalQuantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumorsGenetic variants modulating CRIPTO serum levels identified by genome-wide association study in Cilento isolatesConserved and differential gene interactions in dynamical biological systems.Insight into the heterogeneity of breast cancer through next-generation sequencing.Breast cancer - one term, many entities?Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer StudyLymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53.Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signalingStool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidatesDivide and conquer: the genetic basis of molecular subclassification of breast cancer.DNA methylation profiling reveals a predominant immune component in breast cancers.Heterogeneous DNA Methylation Patterns in the GSTP1 Promoter Lead to Discordant Results between Assay Technologies and Impede Its Implementation as Epigenetic Biomarkers in Breast Cancer.Polymorphisms in bone morphogenetic protein 3 and the risk of papillary thyroid cancer.DNA methylation and hormone receptor status in breast cancer.An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.DNA methylation profiling to assess pathogenicity of BRCA1 unclassified variants in breast cancer.The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition.Role of endogenous insulin gene enhancer protein ISL-1 in angiogenesis.Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinomaIdentification of Genetic and Epigenetic Variants Associated with Breast Cancer Prognosis by Integrative Bioinformatics Analysis.DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.Homeobox A11 hypermethylation indicates unfavorable prognosis in breast cancer.Lessons learned from the intrinsic subtypes of breast cancer in the quest for precision therapy.DNA methylome profiling beyond promoters - taking an epigenetic snapshot of the breast tumor microenvironment.DNA Methylation and Colorectal Cancer
P2860
Q26766285-9533F19F-A2E2-4ADC-A17E-44325A9231F3Q26775086-9904663E-D08D-4384-9181-17C3FBAF7569Q27003285-D2C3915B-D7D0-49AB-9FBF-FDBC7C89D41BQ28305345-042CFF73-0401-433A-91F1-C2B38E12C678Q30910707-9A1BF148-3F6E-46A2-B594-860BEA8E6C19Q31031642-246A04FF-42CF-401E-817A-687C94129955Q33817330-0AB26801-D83A-43AC-87DC-F253B291F01DQ33955013-EF7540C5-1980-42BE-9D25-50A2BAD255A6Q34000385-83C5BE31-67F2-4AC4-B167-68A898B60D40Q34016520-1C5A19FB-18CD-43C5-A9E1-C36BC4FADB4CQ34050656-E5DBC4BB-14E7-4C17-B31B-3D2AE0889344Q34196315-E694CB9A-2565-452C-9544-79E07B0CC35EQ34412268-482B07C6-725E-43BF-9344-1C642FEBD418Q34851281-24F1BC6C-8758-4D43-8089-E40704FA5AA6Q35000317-83DFF0BC-8324-4356-98F3-24F339DBAB3AQ35008011-BDB06E0D-83E6-49C0-8AF2-D30E26867181Q35023500-4073ED28-2BF9-4D3E-9550-05FB1AA79048Q35276364-50291157-A516-4F3D-8AE9-8A13824D1476Q35370090-4F2C8F2C-1F50-4B2A-B089-DDE0DD387B35Q35370118-22CE5B32-3D93-40FC-B385-BC71A3FA4D08Q35674941-2739BC6B-9871-485D-9379-A3372AD02400Q35737352-BF21A1F0-39C9-47CD-A138-8A4B1DEC1262Q35779345-29E04754-7081-4524-87EC-EBC3CFDDF04BQ35798841-37F23100-EEEF-4720-BB3F-1F7739466A11Q36038724-6F662879-19D6-479A-ABFF-1377EFF2B7C7Q36038847-C89CEC01-BCB9-42B0-BA82-A8677D81BA28Q36096510-3B65C11F-6CE3-4109-92A1-D96688218361Q36475937-9DBB0EE3-AE23-4F92-A81C-1A74AD8B174CQ36583742-C1424965-621F-4ECF-98D8-7FEF54378FF0Q36628822-B2CFCE03-EFA5-4183-9277-F5784A7BEE4EQ36833424-FDAF7D82-A328-416F-B041-47B3DBC94ADEQ36924454-795CF760-D90B-4761-AFF9-6A035EA3A064Q37470219-48175A4D-DE47-42DB-ABD8-708C99AA05E6Q37481100-618F3E7D-8ADD-4757-868E-ACC2DC265D09Q37577093-F150B594-0AAA-4A7F-8D0B-4E274692DA62Q37702047-79B7686A-D3C2-4805-BDDF-05BC191167D7Q37706066-AC93FECE-531B-4793-8950-85D47300A30AQ38213543-8AAE2065-F12A-4B0E-A184-8C33F2A41F8BQ38261602-C8B7DB90-7CCF-49F7-A418-8D6E81F69B66Q38314840-67DCBE9F-7991-4C86-88A0-306B324DC92F
P2860
Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Methylation profiling with a p ...... pes in sporadic breast cancer.
@de
Methylation profiling with a p ...... pes in sporadic breast cancer.
@en
type
label
Methylation profiling with a p ...... pes in sporadic breast cancer.
@de
Methylation profiling with a p ...... pes in sporadic breast cancer.
@en
prefLabel
Methylation profiling with a p ...... pes in sporadic breast cancer.
@de
Methylation profiling with a p ...... pes in sporadic breast cancer.
@en
P2093
P2860
P50
P1433
P1476
Methylation profiling with a p ...... pes in sporadic breast cancer.
@en
P2093
Christian Daviaud
Hiroko Kato Solvang
Ida Bukholm
Ivan Potapenko
Jo Anders Rønneberg
P2860
P356
10.1016/J.MOLONC.2010.11.004
P50
P577
2010-11-25T00:00:00Z